Jonathan Barratt, MD, University of Leicester, UK, discusses the need for improved continuity of care for patients with IgA nephropathy. Professor Barratt notes that the rarity of the disease combined with the feeling that IgA nephropathy does not require urgent assessment or treatment leads to a lack of urgency for healthcare professionals to stay up-to-date. He also discusses potential education opportunities and offerings from the IgA Nephropathy Foundation.